The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antithrombotic Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Thrombosis is may be defined as the formation of blood clot in the blood vessel or lumen part of the blood vessel. Formation of blood clots inside the blood vessel causes disruption of blood flow and it leads to cause death of cells. Deep vein thrombosis (DVT) is one type of thrombosis and it affects larger muscle of thigh. As a result, it causes pain, swelling in the leg and also it causes pulmonary embolism. Deep vein thrombosis (DVT) and pulmonary embolism collectively called as venous thromboembolism (VTE). Deep vein thrombosis is usually affects legs, sometimes it also affects chest, arm and other parts of body. If it happens in brain, lungs and heart then that could cause damage of organ.
The global Antithrombotic Drugs market size is expected to reach US$ 27080 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antithrombotic Drugs in various end use industries. The expanding demands from the General Pharmacies, Hospital Pharmacies, Online Retailers and Drug Stores, are propelling Antithrombotic Drugs market. Apixaban, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Debigatran segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antithrombotic Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antithrombotic Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antithrombotic Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antithrombotic Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antithrombotic Drugs covered in this report include Bristol myers squibb pharma, Abbott laboratories, Pliva, Sandoz, Pfizer, Pharmacia, Watson laboratories, Zydus pharmaceuticals usa and Bristol-Myers Squibb, etc.
The global Antithrombotic Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol myers squibb pharma
Abbott laboratories
Pliva
Sandoz
Pfizer
Pharmacia
Watson laboratories
Zydus pharmaceuticals usa
Bristol-Myers Squibb
Global Antithrombotic Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antithrombotic Drugs market, Segment by Type:
Apixaban
Debigatran
Edoxaban
Fondaparinux
Heparin
Rivaroxaban
Global Antithrombotic Drugs market, by Application
General Pharmacies
Hospital Pharmacies
Online Retailers
Drug Stores
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antithrombotic Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antithrombotic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Thrombosis is may be defined as the formation of blood clot in the blood vessel or lumen part of the blood vessel. Formation of blood clots inside the blood vessel causes disruption of blood flow and it leads to cause death of cells. Deep vein thrombosis (DVT) is one type of thrombosis and it affects larger muscle of thigh. As a result, it causes pain, swelling in the leg and also it causes pulmonary embolism. Deep vein thrombosis (DVT) and pulmonary embolism collectively called as venous thromboembolism (VTE). Deep vein thrombosis is usually affects legs, sometimes it also affects chest, arm and other parts of body. If it happens in brain, lungs and heart then that could cause damage of organ.
The global Antithrombotic Drugs market size is expected to reach US$ 27080 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antithrombotic Drugs in various end use industries. The expanding demands from the General Pharmacies, Hospital Pharmacies, Online Retailers and Drug Stores, are propelling Antithrombotic Drugs market. Apixaban, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Debigatran segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antithrombotic Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antithrombotic Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antithrombotic Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antithrombotic Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antithrombotic Drugs covered in this report include Bristol myers squibb pharma, Abbott laboratories, Pliva, Sandoz, Pfizer, Pharmacia, Watson laboratories, Zydus pharmaceuticals usa and Bristol-Myers Squibb, etc.
The global Antithrombotic Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol myers squibb pharma
Abbott laboratories
Pliva
Sandoz
Pfizer
Pharmacia
Watson laboratories
Zydus pharmaceuticals usa
Bristol-Myers Squibb
Global Antithrombotic Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antithrombotic Drugs market, Segment by Type:
Apixaban
Debigatran
Edoxaban
Fondaparinux
Heparin
Rivaroxaban
Global Antithrombotic Drugs market, by Application
General Pharmacies
Hospital Pharmacies
Online Retailers
Drug Stores
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antithrombotic Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antithrombotic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antithrombotic Drugs Market Overview
1.1 Antithrombotic Drugs Product Overview
1.2 Antithrombotic Drugs Market Segment by Type
1.2.1 Apixaban
1.2.2 Debigatran
1.2.3 Edoxaban
1.2.4 Fondaparinux
1.2.5 Heparin
1.2.6 Rivaroxaban
1.3 Global Antithrombotic Drugs Market Size by Type
1.3.1 Global Antithrombotic Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Antithrombotic Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antithrombotic Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antithrombotic Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antithrombotic Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antithrombotic Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antithrombotic Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antithrombotic Drugs Sales Breakdown by Type (2018-2023)
2 Global Antithrombotic Drugs Market Competition by Company
2.1 Global Top Players by Antithrombotic Drugs Sales (2018-2023)
2.2 Global Top Players by Antithrombotic Drugs Revenue (2018-2023)
2.3 Global Top Players by Antithrombotic Drugs Price (2018-2023)
2.4 Global Top Manufacturers Antithrombotic Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antithrombotic Drugs Market Competitive Situation and Trends
2.5.1 Antithrombotic Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antithrombotic Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antithrombotic Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Antithrombotic Drugs Market
2.8 Key Manufacturers Antithrombotic Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antithrombotic Drugs Status and Outlook by Region
3.1 Global Antithrombotic Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antithrombotic Drugs Historic Market Size by Region
3.2.1 Global Antithrombotic Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Antithrombotic Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Antithrombotic Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antithrombotic Drugs Forecasted Market Size by Region
3.3.1 Global Antithrombotic Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Antithrombotic Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Antithrombotic Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antithrombotic Drugs by Application
4.1 Antithrombotic Drugs Market Segment by Application
4.1.1 General Pharmacies
4.1.2 Hospital Pharmacies
4.1.3 Online Retailers
4.1.4 Drug Stores
4.2 Global Antithrombotic Drugs Market Size by Application
4.2.1 Global Antithrombotic Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Antithrombotic Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antithrombotic Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antithrombotic Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antithrombotic Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antithrombotic Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antithrombotic Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antithrombotic Drugs Sales Breakdown by Application (2018-2023)
5 North America Antithrombotic Drugs by Country
5.1 North America Antithrombotic Drugs Historic Market Size by Country
5.1.1 North America Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antithrombotic Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Antithrombotic Drugs Sales in Value by Country (2018-2023)
5.2 North America Antithrombotic Drugs Forecasted Market Size by Country
5.2.1 North America Antithrombotic Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Antithrombotic Drugs Sales in Value by Country (2024-2029)
6 Europe Antithrombotic Drugs by Country
6.1 Europe Antithrombotic Drugs Historic Market Size by Country
6.1.1 Europe Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antithrombotic Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Antithrombotic Drugs Sales in Value by Country (2018-2023)
6.2 Europe Antithrombotic Drugs Forecasted Market Size by Country
6.2.1 Europe Antithrombotic Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Antithrombotic Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Antithrombotic Drugs by Region
7.1 Asia-Pacific Antithrombotic Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Antithrombotic Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antithrombotic Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antithrombotic Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antithrombotic Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Antithrombotic Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antithrombotic Drugs Sales in Value by Region (2024-2029)
8 Latin America Antithrombotic Drugs by Country
8.1 Latin America Antithrombotic Drugs Historic Market Size by Country
8.1.1 Latin America Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antithrombotic Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antithrombotic Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Antithrombotic Drugs Forecasted Market Size by Country
8.2.1 Latin America Antithrombotic Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antithrombotic Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Antithrombotic Drugs by Country
9.1 Middle East and Africa Antithrombotic Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antithrombotic Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antithrombotic Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antithrombotic Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Antithrombotic Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antithrombotic Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bristol myers squibb pharma
10.1.1 Bristol myers squibb pharma Company Information
10.1.2 Bristol myers squibb pharma Introduction and Business Overview
10.1.3 Bristol myers squibb pharma Antithrombotic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol myers squibb pharma Antithrombotic Drugs Products Offered
10.1.5 Bristol myers squibb pharma Recent Development
10.2 Abbott laboratories
10.2.1 Abbott laboratories Company Information
10.2.2 Abbott laboratories Introduction and Business Overview
10.2.3 Abbott laboratories Antithrombotic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abbott laboratories Antithrombotic Drugs Products Offered
10.2.5 Abbott laboratories Recent Development
10.3 Pliva
10.3.1 Pliva Company Information
10.3.2 Pliva Introduction and Business Overview
10.3.3 Pliva Antithrombotic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pliva Antithrombotic Drugs Products Offered
10.3.5 Pliva Recent Development
10.4 Sandoz
10.4.1 Sandoz Company Information
10.4.2 Sandoz Introduction and Business Overview
10.4.3 Sandoz Antithrombotic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sandoz Antithrombotic Drugs Products Offered
10.4.5 Sandoz Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Antithrombotic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Antithrombotic Drugs Products Offered
10.5.5 Pfizer Recent Development
10.6 Pharmacia
10.6.1 Pharmacia Company Information
10.6.2 Pharmacia Introduction and Business Overview
10.6.3 Pharmacia Antithrombotic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Pharmacia Antithrombotic Drugs Products Offered
10.6.5 Pharmacia Recent Development
10.7 Watson laboratories
10.7.1 Watson laboratories Company Information
10.7.2 Watson laboratories Introduction and Business Overview
10.7.3 Watson laboratories Antithrombotic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Watson laboratories Antithrombotic Drugs Products Offered
10.7.5 Watson laboratories Recent Development
10.8 Zydus pharmaceuticals usa
10.8.1 Zydus pharmaceuticals usa Company Information
10.8.2 Zydus pharmaceuticals usa Introduction and Business Overview
10.8.3 Zydus pharmaceuticals usa Antithrombotic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Zydus pharmaceuticals usa Antithrombotic Drugs Products Offered
10.8.5 Zydus pharmaceuticals usa Recent Development
10.9 Bristol-Myers Squibb
10.9.1 Bristol-Myers Squibb Company Information
10.9.2 Bristol-Myers Squibb Introduction and Business Overview
10.9.3 Bristol-Myers Squibb Antithrombotic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bristol-Myers Squibb Antithrombotic Drugs Products Offered
10.9.5 Bristol-Myers Squibb Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antithrombotic Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antithrombotic Drugs Industrial Chain Analysis
11.4 Antithrombotic Drugs Market Dynamics
11.4.1 Antithrombotic Drugs Industry Trends
11.4.2 Antithrombotic Drugs Market Drivers
11.4.3 Antithrombotic Drugs Market Challenges
11.4.4 Antithrombotic Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antithrombotic Drugs Distributors
12.3 Antithrombotic Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
